CLYM NASDAQ
Climb Bio, Inc.
1W: -6.2%
1M: -6.0%
3M: +29.4%
YTD: +227.7%
1Y: +747.6%
$12.29
-0.50 (-3.91%)
Weekly Expected Move ±8.5%
$11
$12
$13
$14
$15
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$838.0M
52W Range1.36-14.415
Volume935,992
Avg Volume1,246,617
Beta0.07
Dividend—
Analyst Ratings
Company Info
CEOAoife Brennan BCh MMSc
Employees29
SectorHealthcare
IndustryBiotechnology
IPO Date2021-08-10
Websiteclimbbio.com
20 William Street
Wellesley Hills, MA 02481
US
Wellesley Hills, MA 02481
US
866 857 2596
About Climb Bio, Inc.
Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.
Latest News
Climb Bio (NASDAQ:CLYM) Shares Up 10.9% Following Analyst Upgrade
Climb Bio (NASDAQ:CLYM) Sets New 52-Week High Following Analyst Upgrade
Oppenheimer’s ‘best of the best’ momentum list: NVDA, LRCX and more
Is Artiva Biotherapeutics, Inc. (ARTV) Outperforming Other Medical Stocks This Year?
Why Is Climb Bio Stock Gaining Friday?
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Celebi Breanna Mauri | A-Award | 70,284 | $13.36 | 2026-06-29 |
| Celebi Breanna Mauri | 0 | — | 2026-06-29 | |
| RA CAPITAL MANAGEMEN | A-Award | 70,284 | $13.36 | 2026-06-29 |
| Brennan Aoife | S-Sale | 30,902 | $13.17 | 2026-06-29 |
| Brennan Aoife | M-Exempt | 68,750 | — | 2026-06-27 |